Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 44, 2014 - Issue 21
757
Views
0
CrossRef citations to date
0
Altmetric
Miscellany

Statement of Retraction

This article refers to:
One-Pot Synthesis of [1,2]Isoxazolidin-5-ones and [1,2]Oxazin-6-ones

We, the Editor and Publisher of Synthetic Communications, are retracting the following article:

Aïcha Arfaoui, Imen Beltaïef, and Hassen Amri, One-Pot Synthesis of [1,2]Isoxazolidin-5-ones and [1,2]Oxazin-6-ones,” Synthetic Communications, 41.10 (2011): 1536–1543, http://dx.doi.org/10.1080/00397911.2010.487292

We are now cognizant that a substantially similar version of this article was simultaneously submitted to and published in the journal Molecules:

Aïcha Arfaoui, Imen Beltaïef, and Hassen Amri, “An Expeditious Synthesis of [1,2]Isoxazolidin-5-ones and [1,2]Oxazin-6-ones from Functional Allyl Bromide Derivatives,” Molecules, 15.6 (2010): 4094–4101, http://dx.doi.org/10.3390/molecules15064094

This action constitutes a breach of warranties made by the authors. We note that we received, peer-reviewed, accepted, and published the article in good faith based on these warranties, and censure this action.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as RETRACTED.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.